Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-07T08:47:44.098Z Has data issue: false hasContentIssue false

The developmental environment, epigenetic biomarkers and long-term health

Published online by Cambridge University Press:  28 May 2015

K. M. Godfrey*
Affiliation:
MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK
P. M. Costello
Affiliation:
Institute of Developmental Sciences, Academic Unit of Human Development and Health, University of Southampton, Southampton, UK
K. A. Lillycrop
Affiliation:
Centre for Biological Sciences, University of Southampton, Southampton, UK
*
*Address for correspondence: Professor K. Godfrey, MRC Lifecourse Epidemiology Unit, NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, SO16 6YD, UK. (Email kmg@mrc.soton.ac.uk)
Rights & Permissions [Opens in a new window]

Abstract

Evidence from both human and animal studies has shown that the prenatal and early postnatal environments influence susceptibility to chronic disease in later life and suggests that epigenetic processes are an important mechanism by which the environment alters long-term disease risk. Epigenetic processes, including DNA methylation, histone modification and non-coding RNAs, play a central role in regulating gene expression. The epigenome is highly sensitive to environmental factors in early life, such as nutrition, stress, endocrine disruption and pollution, and changes in the epigenome can induce long-term changes in gene expression and phenotype. In this review we focus on how the early life nutritional environment can alter the epigenome leading to an altered susceptibility to disease in later life.

Information

Type
Review
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2015 
Figure 0

Fig. 1 DNA methylation and histone modifications are two epigenetic modifications that determine the chromatin structure and the ability for genes to be transcribed. The processes interact and can lead to open chromatin and gene transcription or to closed chromatin and gene silencing. DNMT, DNA methyltransferase.

Figure 1

Fig. 2 Epigenetic biomarkers; detecting early life epigenetic biomarkers that are associated with disease risk could lead to stratified interventions and reduced susceptibly to chronic disease. ncRNA, non-coding RNA.